RT @AngeloDipa_: How to choose between Lenvatinib and Sorafenib in 1st line treatment of advanced #HCC❓ And what is the role of TKIs in Ate…
RT @AngeloDipa_: How to choose between Lenvatinib and Sorafenib in 1st line treatment of advanced #HCC❓ And what is the role of TKIs in Ate…
RT @AngeloDipa_: How to choose between Lenvatinib and Sorafenib in 1st line treatment of advanced #HCC❓ And what is the role of TKIs in Ate…
A Comparison of Lenvatinib versus Sorafenib in the First-Line Treatment of Unresectable Hepatocellular Carcinoma: Selection Criteria to Guide Physician’s Choice in a New Therapeutic Scenario https://t.co/VHiEIGANni
How to choose between Lenvatinib and Sorafenib in 1st line treatment of advanced #HCC❓ And what is the role of TKIs in Atezo/Beva era❓ 👉🏻 Take a look to our review and find it out‼️ @DovePress @OncoAlert @ONcotwITting https://t.co/y637Xrkrqf https://t.